Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 5.11.2018 | EN | Official Journal of the European Union | C 399/34 |

---

Judgment of the General Court of 20 September 2018 — Kwizda Holding v EUIPO — Dermapharm (UROAKUT)

(Case T-266/17) [(1)](#ntr1-C_2018399EN.01003401-E0001)

((EU trade mark - Opposition proceedings - Application for EU word mark UROAKUT - Earlier national and international figurative marks UroCys - Relative ground for refusal - Lack of likelihood of confusion - Power to amend decisions - Article 8(1)(b) of Regulation No (EC) 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001)))

(2018/C 399/46)

Language of the case: German

Parties

Applicant: Kwizda Holding GmbH (Vienna, Austria) (represented by: L. Wiltschek, D. Plasser and K. Majchrzak, lawyers)

Defendant: European Union Intellectual Property Office (represented by: S. Hanne, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Dermapharm GmbH (Vienna) (represented by: H. Kunz-Hallstein and R. Kunz-Hallstein, lawyers)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 7 March 2017 (Case R 1221/2016-4) concerning opposition proceedings between Dermapharm and Kwizda Holding.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Annuls the decision of the Fourth Board of Appeal of European Union Intellectual Property Office (EUIPO) of 7 March 2017 (Case R 1221/2016-4); |

|  |  |
| --- | --- |
| 2. | Rejects the opposition brought by Dermapharm GmbH; |

|  |  |
| --- | --- |
| 3. | Orders EUIPO to bear its own costs and the costs incurred by Kwizda Holding GmbH, including the costs incurred before the Board of Appeal; |

|  |  |
| --- | --- |
| 4. | Orders Dermapharm to bear its own costs. |

---

---

[Top](#document1)